J. Biol. Chem., Vol. 262, Issue 36, 17285-17293, 12, 1987

Epidermal growth factor and angiotensin II stimulate formation of inositol 1,4,5- and inositol 1,3,4-trisphosphate in hepatocytes. Differential inhibition by pertussis toxin and phorbol 12-myristate 13- acetate

RM Johnson and JC Garrison
Department of Pharmacology, University of Virginia School of Medicine, Charlottesville 22908.

The ability of epidermal growth factor (EGF) and angiotensin II to stimulate production of inositol trisphosphate and mobilize intracellular Ca2+ in hepatocytes was compared using quin2 fluorescence to monitor changes in Ca2+ levels and high performance liquid chromatography to resolve the inositol trisphosphate (InsP3) isomers. Both EGF and angiotensin II stimulated an increase in free intracellular Ca2+ concentration ([Ca2+]i) as well as a rapid increase in the production of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3). Concentrations of angiotensin II which gave a rise in [Ca2+]i equivalent to that seen with maximal doses of EGF produced an equivalent increase in Ins(1,4,5)P3 formation. Both EGF and angiotensin II stimulated the formation of the Ins(1,3,4)P3 and inositol 1,3,4,5- tetrakisphosphate isomers. The formation of the Ins(1,3,4)P3 isomer lagged behind production of Ins(1,4,5)P3 but eventually reached higher levels in the cell. The initial rise in [Ca2+]i and InsP3 levels stimulated by EGF and angiotensin II was not affected by reducing the external Ca2+ concentration below 30 nM with an excess of [ethylenebis(oxyethylenenitrilo)] tetraacetic acid. Treatment of hepatocytes for 30-180 s with 1 micrograms/ml phorbol 12-myristate 13- acetate prior to the addition of EGF blocked the EGF-stimulated production of Ins(1,4,5)P3 and the increase in [Ca2+]i. Phorbol 12- myristate 13-acetate attenuated the production of Ins(1,4,5)P3 generated by angiotensin II over the concentration range of 10(-10) to 10(-8) M; however, the Ca2+ signal was only inhibited at the 10(-10) M dose of angiotensin II. Treatment of rats with pertussis toxin for 72 h prior to isolating hepatocytes blocked the ability of EGF to increase Ins(1,4,5)P3 and Ins(1,3,4)P3 but did not inhibit the ability of any concentration of angiotensin II to stimulate formation of InsP3 or inositol tetrakisphosphate. The observation that pertussis toxin selectively abolishes EGF-stimulated inositol lipid breakdown suggests that EGF and angiotensin II use different mechanisms to activate phospholipase C in hepatocytes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. B. Patel Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades Pharmacol. Rev., September 1, 2004; 56(3): 371 - 385. [Abstract] [Full Text] [PDF]

				K. Imai, T. Mine, M. Tagami, K. Hanaoka, and T. Fujita Zonal differences in effects of HGF/SF and EGF on DNA synthesis in hepatocytes under fed or starved conditions Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1394 - G1401. [Abstract] [Full Text] [PDF]

				K. Collison, S. Saleh, R. Parhar, B. Meyer, A. Kwaasi, K. Al-Hussein, S. Al-Sedairy, and F. Al-Mohanna Evidence for IL-12-Activated Ca2+ and Tyrosine Signaling Pathways in Human Neutrophils J. Immunol., October 1, 1998; 161(7): 3737 - 3745. [Abstract] [Full Text] [PDF]

				J. B. Thompson, S. M. Wade, J. K. Harrison, M. N. Salafranca, and R. R. Neubig Cotransfection of Second and Third Intracellular Loop Fragments Inhibit Angiotensin AT1a Receptor Activation of Phospholipase C in HEK-293 Cells J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 216 - 222. [Abstract] [Full Text]

				K. Seedorf, M. Shearman, and A. Ullrich Rapid and Long Term Effects of Protein Kinase C on Receptor Tyrosine Kinase Phosphorylation and Degradation J. Biol. Chem., August 11, 1995; 270(32): 18953 - 18960. [Abstract] [Full Text] [PDF]

				E.-J. Yeo and J. H. Exton Stimulation of Phospholipase D by Epidermal Growth Factor Requires Protein Kinase C Activation in Swiss 3T3 Cells J. Biol. Chem., February 24, 1995; 270(8): 3980 - 3988. [Abstract] [Full Text] [PDF]

				J Lyons, C. Landis, G Harsh, L Vallar, K Grunewald, H Feichtinger, Q. Duh, O. Clark, E Kawasaki, H. Bourne, et al. Two G protein oncogenes in human endocrine tumors Science, August 10, 1990; 249(4969): 655 - 659. [Abstract] [PDF]

				R. Johnson, W. Wasilenko, R. Mattingly, M. Weber, and J. Garrison Fibroblasts transformed with v-src show enhanced formation of an inositol tetrakisphosphate Science, October 6, 1989; 246(4926): 121 - 124. [Abstract] [PDF]

				S. Rhee, P. Suh, S. Ryu, and S. Lee Studies of inositol phospholipid-specific phospholipase C Science, May 5, 1989; 244(4904): 546 - 550. [Abstract] [PDF]

				M. Wahl, T. Daniel, and G Carpenter Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells Science, August 19, 1988; 241(4868): 968 - 970. [Abstract] [PDF]